U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07133893) titled 'Transcranial Photobiomodulation in Anxiety Disorders' on July 24.
Brief Summary: The investigators have previously shown that safe, non-invasive methods of brain stimulation such as the administration of transcranial infrared light can result in improvements to cognition and emotion. The investigators hypothesize that transcranial photobiomodulation (tPBM) can be used in conjunction with attention bias assessment and modification to reduce anxiety symptoms in individuals with sub-clinical anxiety.
Study Start Date: Sept., 2025
Study Type: INTERVENTIONAL
Condition:
Symptoms of Anxiety
Intervention:
BEHAVIORAL: Attention bias as...